Three trials were conducted to evaluate the effect of lactic acid-producing microbial feed additives (Probiotics) on performance of starting and growing-finishing pigs. Two commercially available probiotics, Probios (L. acidopbilus) and Feed-Mate 68 (Streptococcus faeciurn type Cernelle 68), were used. In the first of two starter trials, 192 crossbred pigs (initial weight 7 kg) were used in a 2 • 4 factorial arrangement of treatments, with Probios and antibiotics (ASP-250, lincomycin, tylosin) as the main effects. Addition of antibiotics, regardless of source, improved (P<.05) average daily gain (ADG) and feed conversion (FC). ADG and FC were improved by 2.6 and 3.6%, respectively, with probiotics (P< .10). A suggestion of an additive effect was observed for lincomycin plus Probios. In the second trial, with 224 pigs, virginiamycin was evaluated in combination with Probios, Feed-Mate 68 and DL-lactic acid. The antibiotic effect was not significant; addition of probiotic products and DL-lactic acid improved FC (P<.05). Probios improved ADG 9.7% and FC 4.4%, while Feed-Mate 68 decreased performance. A growing-finishing trial was conducted with 144 crossbred pigs (average initial weight 34 kg) to determine the effect of probiotics, lincomycin or a combination on ADG and FC of growingfinishing swine. Probiotics did not affect performance, but addition of lincomycin increased ADG by 3.6% (P<.05) and FC by 2.5% (P<.IO).
Introduction
The importance of maintaining an ideal intestinal flora in swine has been recognized for many years. In the past few decades, the most common method of repressing the nondesirable microorganisms has been treatment with antibacterial agents. Since future legislation may prohibit the use of subtherapeutic levels of antibacterials, the use of probiotics as a possible alternative to antibiotics has received renewed interest. Metchnikoff (1908) speculated on the harmful role of intestinal fermentation caused by proteolytic and putrifying organisms, noting that it can lead to autointoxication. The recommended solution was the addition of lactic acid-producing bacteria (lactobacilli) in an effort to establish a "desirable" microflora population in the intestinal tract.
Several possible modes of action for lactobacilli benefits have been suggested: (1) change in enteric flora and reduction of E. coli (Porter and Kenworthy, 1969; Hill et al., 1970a,b; Moon, 1975; Mitchell and Kenworthy, 1976; Muralidhara et al., 1977) ; (2) production of antibiotic substances (Shahani et al., 1976 (Shahani et al., , 1977 ; (3) synthesis of lactate with concomitant reduction in intestinal pH (White et al., 1969; Herrick, 1972) ; (4) adhesion to or colonization in the digestive tract (Fuller and Brooker, 1974; Muralidhara et al., 1977) and (5) prevention of toxic amine synthesis (Hill et al., 1970a,b) .
Lactobacillus therapy has been shown to help improve gain and feed efficiency in poultry (Tortuero, 1973; Fuller and Brooker, 1974) and swine (Parker, 1975; Baird, 1977; Hale and Newton, 1979) . However, other researchers (Hines and Koch, 1971; Mahan and Newland, 1976; Cline et al., 1976; Holden, 1976) have observed no significant response in swine. The efficacy of lactobacillus products has not been fully elucidated. Streptococcus faeciurn (lactic acid-producing bacteria) Cernelle 68, was evaluated in combination with virginiamycin 8 (110 mg/kg) in a 2 • 4 factorial arrangement of treatments with 224 crossbred pigs (14 pigs/treatment, two replications). DL-lactic acid (LA), added at 220 mg/kg, was also evaluated in an attempt to discover whether the lactic acid produced by these bacterial cultures is the cause of their effect on performance. The experimental treatments were: (1) control, (2) Probios, (3) Feed-Mate 68, (4) LA, (5)virginiamycin, (6) virginiamycin + Probios, (7) virginiamycin + Feed-Mate 68 and (8) virginiamycin + LA. The additives were included in the basal diet (table 1), which was fed ad libitum for 28 days in the same nursery in which trial 1 was conducted. Pigs were allotted to the treatments by initial weight (average 7 kg) on the day of weaning.
Growing-Finishing Trial.
A growing-finishing trial was conducted to evaluate the effect of S.
faeciurn and lactobacillus probiotics in lincomycin-medicated diets on gain and feed efficiency. A 2 • 3 factorial arrangement of treatments was used, with lincomycin and probiotic source as the main effects. The 144 crossbred pigs (six pigs/treatment, four replications) were allotted to treatment by initial weight (average 34 kg) and sex. The pigs were housed in outdoor pens with a concrete apron and shelter, and fed ad libitum. The pigs received a 16% corn-soy diet until they reached approximately 57 kg and a 14% diet (table 2) thereafter until termination of the study. The treatments were: (1) control, (2) Probios (500 mg/kg), (3) Feed-Mate 68 (500 mg/kg), (4) lincomycin (110 mg/kg), (5) Probios + lincomycin and (6) Feed-Mate 68 + lincomycin.
Data were analyzed by least-squares analysis of variance (Harvey, 1960) . The orthogonal comparison for the main effects and interactions were performed by methods described by Snedecor and Cochran (1967) .
Results and Discussion
Starter Trials. The effect of Probios in medicated diets on performance of young pigs is shown in table 3. The addition of antibiotics, regardless of source, improved average daily gain (ADG) and feed conversion (FC) (P<.05). There were no significant differences between sources of antibiotics. There was a trend for improved ADG (2.6%) and FC (3.6%) in pigs fed probiotics compared to nontreated animals. In the groups not receiving antibiotics, Probios improved ADG 4.5% and FC 7.2%. When Probios was added to an ASP-250 or tylosinmedicated diet, a reduction in ADG was observed. Lincomycin produced better ADG when fed in combination with Probios than without (.307 versus .265 kg), suggesting a possible additive effect.
In the second trial ( It has been suggested that the lactic acid produced as a metabolite during fermentation of a lactic acid-producing bacterial culture is the cause of any improvement in performance. The lactic acid treatment without virginiamycin produced the best feed conversion.
Growing-Finishing Trial. The results of the growing-finishing trial in which Feed-Mate 68 and Probios were fed in lincomycin-medicated diets are presented in table 5. Lincomycin was selected as the antibiotic because of the possible additive effect that was observed when it was fed in combination with probiotics in the starter diet in trial 1. The lincomycin-medicated groups showed improved ADG (P<.05) and FC (P<.10) by comparison with the nonmedica- The data suggest that the two commercial probiotic products that were evaluated performed differently. It appears that the lactobacillus product is superior to the streptococcal product as an additive to pig starter diets. A greater response was observed with starting than with growing-finishing pigs. Baird (1977) conducted three trials with feeder pigs with Probios added at 500 mg/kg and observed an improvement in ADG (10.8%) and FC (7.2%), a finding which is similar to the results observed here. Baird also observed an improvement in ADG (8.45%) and FC (5.8%) in growing-finishing pigs. Other researchers (Hines and Koch, 1971; Holden, 1976; Mahan and Newland, 1976; Cline et al., 1976) have observed no response when Probios was added to swine diets.
With the possibility of discontinued use of subtherapeutic levels of antibacterial agents, probiotics could be an alternative for microbial population control in the digestive tract of swine.
